Similar User
@oncoOuLungCA
@fred_hirsch
@MNagasaka
@Joshua_Reuss
@LuisRaezMD
@LeXiuning
@LudaBazhenovaMD
@JessicaJLinMD
@danieltanmd
@t_mitsudomi
@JustinGainor
@DrMarkAwad
@MartinReck2
@MMarmarelis
@YYElamin
Our paper just out on Cancer Cell: IO inductive therapy let 25% unresectable stage 3 NSCLC become resectable and more patients without recurrence than that received CCRT. Thanks all investigators from 15 sites in China. It is impossible without their hard works!
Online Now: Neoadjuvant SHR-1701 with or without chemotherapy in unresectable stage III non-small-cell lung cancer: A proof-of-concept, phase 2 trial dlvr.it/T8YhfC
🎙️ Early undetectable ctDNA during CRT 🔁⬆️OS in #lungcancer‼️@OncoAlert 📌Retro study of 761 blood samples from 139 👥 undergoing RT 🥇🎯: Study on ctDNA during chemoradiotherapy (CRT) in #nonsmall cell lung cancer RESULTs📊 👉ctDNA levels ⬇️ significantly during CRT at on-RT…
Our paper on First-line pyrotinib in advanced HER2+NSCLC: a patient-centric phase 2 trial rdcu.be/dhCoA. online at Nature Medicine. Thanks Drs. Grant and Goldberg for your comments: "Precise, pragmatic and inclusive: the modern era of oncology clinical trials.
Treatment of patients with HER2-mutant non-small cell lung cancer with pyrotinib in a phase 2 trial or compassionate use showed a favourable objective response rate, while patients treated in parallel by physician's choice in a real-world study did not. nature.com/articles/s4159…
Our review in rdcu.be/dagfs Emerging evidence and treatment paradigm of non-small cell lung cancer
Neoadjuvant SHR-1701 Increases Response, Resectability in Stage III Unresectable NSCLC onclive.com/view/neoadjuva… via @onclive
Did you know IASLC members receive special access to the IASLC’s virtual libraries for all meetings including previous WCLC’s and other IASLC meetings? JOIN or RENEW today! bit.ly/3Fy6otr #LCSM
Did you know IASLC members receive special access to the IASLC’s virtual libraries for all meetings including previous WCLC’s and other IASLC meetings? JOIN or RENEW today! bit.ly/3Fy6otr #LCSM
dailyreporter.esmo.org/esmo-immuno-on… Neoadjuvant PD1-TGF with chemo better than PD1-TGF mono in PD-L1>50% NSCLC and 25.2% surgery conversion in 3A-3C unresectable NSCLC.
ESMO IO Proffered Paper session <small>(ID 21)</small> cslide.ctimeetingtech.com/immuno22hybrid…
Researchers highlighted new #lungcancer study data from around the world during #WCLC22. Catch up on those presentations in ILCN: ow.ly/aKcn50KgltS #LCSM
Consolidation Sugemalimab Provides Sustained PFS Benefit in Unresectable Stage III NSCLC onclive.com/view/consolida… via @onclive The first phase 3 trial showed that sCRT followed by sugemalimab could give stage 3 unresectable patients survival benefit.
🌟ONLINE NOW @LungCaJournal “ “Perioperative targeted therapy for oncogene-driven NSCLC” by @ThomasW35874311 et al #LCSM 🟥Read it here: lungcancerjournal.info/action/showPdf…
Our review Perioperative Target Therapy for Oncogene-Driven NSCLC online on LUNG CANCER
Pembrolizumab Maintains Survival Benefits in 4-year Follow-Up of KEYNOTE-042 in NSCLC in China onclive.com/view/pembroliz… via @onclive
Proud to be involved with this important @myESMO consensus statement. Do check out the section on stage 3 EGFRm NSCLC #LCSM @Annals_Oncology
🆕🌟I’m very proud to share our last manuscript titled “ESMO expert consensus statements on the management of EGFR mutant Non-Small Cell #LungCancer” #LCSM A global effort to improve the management of EGFR-positive disease Thanks to all the authors!!! annalsofoncology.org/article/S0923-…
Special thanks to @BostonMagazine for highlighting Dr. Pasi Janne as Top Doctor. We are grateful to have an amazing leader that continues to find the latest research efforts to treat patients with EGFR-Mutant Lung Cancers. bit.ly/3rUAIGp @EGFRResisters @GO2Foundation
United States Trends
- 1. Serrano 110 B posts
- 2. #TysonPaul 67,6 B posts
- 3. #NetflixFight 35,7 B posts
- 4. Ramos 62,9 B posts
- 5. #buffering 5.627 posts
- 6. #netflixcrash 2.943 posts
- 7. Rosie Perez 7.736 posts
- 8. My Netflix 45,4 B posts
- 9. ROBBED 48,7 B posts
- 10. Jerry Jones 6.569 posts
- 11. #SmackDown 65,9 B posts
- 12. WTF Netflix 10,6 B posts
- 13. Cedric 1.062 posts
- 14. Christmas Day 13,5 B posts
- 15. Love is Blind 4.181 posts
- 16. The Netflix 201 B posts
- 17. $NFLX 4.324 posts
- 18. Streameast 2.270 posts
- 19. Peter 150 B posts
- 20. Goyat 24,4 B posts
Who to follow
-
Sai-Hong Ignatius Ou
@oncoOuLungCA -
Fred R. Hirsch
@fred_hirsch -
Misako Nagasaka
@MNagasaka -
Joshua Reuss
@Joshua_Reuss -
Dr. Luis E. Raez
@LuisRaezMD -
Xiuning Le MD PhD
@LeXiuning -
LudaBazhenovaMD
@LudaBazhenovaMD -
JessicaJLinMD
@JessicaJLinMD -
Daniel Tan
@danieltanmd -
Tetsuya Mitsudomi
@t_mitsudomi -
Justin Gainor
@JustinGainor -
Mark Awad
@DrMarkAwad -
Martin Reck
@MartinReck2 -
Melina Marmarelis
@MMarmarelis -
Yasir Yousif Elamin
@YYElamin
Something went wrong.
Something went wrong.